Biopsy Devices Market Projected to Reach $2.83 Billion by 2031

The global market for biopsy devices is projected to reach USD 2.83 billion by 2031, expanding from an estimated USD 2.33 billion in 2026. The market is anticipated to grow at a compound annual growth rate (CAGR) of 3.97% during the forecast period, according to Mordor Intelligence.

Key drivers for market expansion include the increasing demand for early cancer diagnosis, the growing adoption of image-guided biopsy procedures, and advancements in minimally invasive sampling technologies. These devices are crucial for diagnosing cancer and other abnormalities, utilized across hospitals, diagnostic centers, and ambulatory surgical facilities.

Technological advancements are significantly shaping the market landscape. Manufacturers are focusing on improved needle designs, biopsy instruments compatible with advanced imaging platforms, and the integration of robotic navigation and AI-assisted imaging. The development of disposable biopsy products aims to enhance targeting accuracy and infection control.

North America currently holds the largest share of the market, supported by its robust healthcare infrastructure and access to advanced diagnostic imaging. The Asia-Pacific region is emerging as a significant growth area, driven by expanding healthcare infrastructure and increased awareness of early cancer detection.